421. <i>In vitro</i> and <i>in vivo</i> synergistic antimicrobial activities of the combinations of meropenem, colistin, tigecycline, and ceftolozane/tazobactam against carbapenem-resistant <i>Klebsiella pneumoniae</i>
Open forum infectious diseases